Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jaya Real Property Tbk. (JRPT) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Jaya Real Property Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Jaya Real Property Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Jaya Real Property Tbk. trades at Rp1,080 (market cap 13.94T, 202.6K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Jaya Real Property Tbk. and Tempo Scan Pacific Tbk. are close in size by market cap, and Tempo Scan Pacific Tbk. is more actively traded (235.2K versus 202.6K). Which is the better fit depends on your goals.

JRPTTSPC
Market Cap
13.94T12.58T
Volume
202.6K235.2K
Lot
2.03K2.35K
Turnover
218.8M649.94M
Average Price
1,079.982,763.37
Value
218.8M649.94M
Indicative Equilibrium Price
1,0802,780
Indicative Equilibrium Volume
2K9

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JRPT
View details
TSPC
View details

About Jaya Real Property Tbk.

PT Jaya Real Property Tbk (the Company) was established under Domestic Investment Law on May 25, 1979, based on the notarial deed No. 36 of Hobropoerwanto, S.H., at that time a notary in Jakarta, and amended with notarial deed No. 14 of the same notary as of December 6, 1979.. Jaya Real Property is the largest property company (in terms of market capitalization) listed on the JSX. It is a wholly owned subsidiary of PT Pembangunan Jaya (the Jaya Group), which is the oldest established property developer.

Read more on JRPT

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC